China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135483
Registration Time: 2026/10/30
Type: Interventional study
Primary Sponsor: Huashan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342966
Published by HT Digital Content Services with permission from Health Daily Digest....